|
|
||||||||
- and Bacteria-Induced IL-8 and IL-1ß Secretion from Intestinal Epithelial Cells1



*
Department of Gastroenterology, Chaim Sheba Medical Center, Tel-HaShomer, Israel; and
Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel
Intestinal epithelial cells secrete proinflammatory cytokines and
chemokines that are crucial in mucosal defense. However, this secretion
must be tightly regulated, because uncontrolled secretion of
proinflammatory mediators may lead to chronic inflammation and mucosal
damage. The aim of this study was to determine whether somatostatin,
secreted within the intestinal mucosa, regulates secretion of cytokines
from intestinal epithelial cells. The spontaneous as well as TNF-
-
and Salmonella-induced secretion of IL-8 and IL-1ß
derived from intestinal cell lines Caco-2 and HT-29 was measured after
treatment with somatostatin or its synthetic analogue, octreotide.
Somatostatin, at physiological nanomolar concentrations, markedly
inhibited the spontaneous and TNF-
-induced secretion of IL-8 and
IL-1ß. This inhibition was dose dependent, reaching >90% blockage
at 3 nM. Furthermore, somatostatin completely abrogated the increased
secretion of IL-8 and IL-1ß after invasion by
Salmonella. Octreotide, which mainly stimulates
somatostatin receptor subtypes 2 and 5, affected the secretion of IL-8
and IL-1ß similarly, and the somatostatin antagonist
cyclo-somatostatin completely blocked the somatostatin- and
octreotide-induced inhibitory effects. This inhibition was correlated
to a reduction of the mRNA concentrations of IL-8 and IL-1ß. No
effect was noted regarding cell viability. These results indicate that
somatostatin, by directly interacting with its specific receptors that
are expressed on intestinal epithelial cells, down-regulates
proinflammatory mediator secretion by a mechanism involving the
regulation of transcription. These findings suggest that somatostatin
plays an active role in regulating the mucosal inflammatory response of
intestinal epithelial cells after physiological and pathophysiological
stimulations such as bacterial invasion.
This article has been cited by other articles:
![]() |
S. Saksena, S. Theegala, N. Bansal, R. K. Gill, S. Tyagi, W. A. Alrefai, K. Ramaswamy, and P. K. Dudeja Mechanisms underlying modulation of monocarboxylate transporter 1 (MCT1) by somatostatin in human intestinal epithelial cells Am J Physiol Gastrointest Liver Physiol, November 1, 2009; 297(5): G878 - G885. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Helyes, E. Pinter, K. Sandor, K. Elekes, A. Banvolgyi, D. Keszthelyi, E. Szoke, D. M. Toth, Z. Sandor, L. Kereskai, et al. Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice PNAS, August 4, 2009; 106(31): 13088 - 13093. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vojdani, J. Lambert, and G. Kellermann The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III Evid. Based Complement. Altern. Med., July 21, 2009; (2009) nep064v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bogunovic, S. H. Dave, J. S. Tilstra, D. T. W. Chang, N. Harpaz, H. Xiong, L. F. Mayer, and S. E. Plevy Enteroendocrine cells express functional Toll-like receptors Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1770 - G1783. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Haque, F Bowe, R J Fitzhenry, G Frankel, M Thomson, R Heuschkel, S Murch, M P Stevens, T S Wallis, A D Phillips, et al. Early interactions of Salmonella enterica serovar typhimurium with human small intestinal epithelial explants Gut, October 1, 2004; 53(10): 1424 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zavros, S. Rathinavelu, J. Y. Kao, A. Todisco, J. Del Valle, J. V. Weinstock, M. J. Low, and J. L. Merchant Treatment of Helicobacter gastritis with IL-4 requires somatostatin PNAS, October 28, 2003; 100(22): 12944 - 12949. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Salh, K. Assi, V. Templeman, K. Parhar, D. Owen, A. Gomez-Munoz, and K. Jacobson Curcumin attenuates DNB-induced murine colitis Am J Physiol Gastrointest Liver Physiol, June 9, 2003; 285(1): G235 - G243. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |